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Material and Methods: Cranial radiosurgical treatments are 
planned in our department using IMRT technique. A Varian 
Clinac 2100 CD equipped with the OBI system and the Eclipse 
TPS are used. Patients are immobilized using the BrainLAB 
mask system. A CBCT scan is acquired after the initial laser-
based patient setup (CBCTsetup). In order to take into 
account the roll and tilt patient´s rotation errors, not 
supported by the linac couch, an online adaptive replanning 
procedure was designed (Med Dosim. 2013 Autumn;38(3):291-
7). It consists of a 6D registration-based mapping of the 
reference plan onto actual CBCTsetup, followed by a 
reoptimization of the beam fluences ("6D plan", computed on 
the CBCTsetup) to achieve similar dosage as originally was 
intended, while the patient is lying in the linac couch. Once 
the 6D plan is computed, it is activated in the record and 
verify network and the actual patient's position is again 
verified by CBCT imaging (CBCTtx): CBCTsetup/CBCTtx 4D 
match is performed on the OBI workstation.  
Twelve online procedures with detected roll or tilt rotation 
errors larger than 0.5º were enrolled in this study. 
Intrafractional patient's shifts during the time lag between 
CBCTsetup and CBCTtx was investigated, as well as the 
capability of the online adaptive method to compensate 
them. The plan 6D plan was recalculated on the CBCTtx ("6D 
plan Tx") taking into account the actual treatment isocenter 
position. Both plans (6D plan vs. 6D plan Tx) were compared 
using DVHs.  
 
Results: 
1) The magnitudes of the intrafraction shifts were 0.4 mm 
(SD: 0.7 mm), 0.6 mm (SD: 0.5 mm) and 0.3 mm (SD: 0.4 mm) 
in lateral, anterior-posterior and superior-inferior directions, 
respectively. The intrafractional rotational shifts were 0.1º 
(SD: 0.1º), 0.0º (SD: 0.1º) and 0.1º (SD: 0.2º) in tilt, yaw and 
roll directions, respectively. The time lag where these shifts 
were happen was 16 ± 2 minutes.  
2) Dose differences < 1% were found for targets and organ-at-
risks between each 6D Plan (computed on the CBCTsetup) 
and its respective 6D Plan Tx (computed on the CBCTtx). 
 
Conclusion: 
1) Patient's rotational errors during online replanning were 
negligible.  
2) Patient's translational errors during online replanning were 
compensated enough after CBCTsetup/CBCTtx 4D alignment 
performed on the OBI workstation, with no appreciable 
dosimetric impact. 
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Purpose or Objective: To investigate the impact of inter-
fraction anatomical variations in pancreatic and pelvic tumor 
patients when using carbon ion therapy through a 
retrospective adaptive approach. 
 
Material and Methods: We collected daily MVCT scans for 10 
selected patients, previously treated with helical 
tomotherapy for tumors located in the abdomen and pelvic 
region. On the first MVCT, taken as a reference, a dummy 
target volume was contoured, based on clinical experience, 
and organs at risk (OAR) original contours were imported 
from the planning CT scan and modified according to 
anatomical variations. The Hounsfield Unit (HU) to water 
equivalent path length (WEPL) calibration curve was 
experimentally determined and implemented in our TPS. 
According to prescription dose and OARs dose limits of 
clinical protocols approved at CNAO, a plan was then 
optimized on the first MVCT. For each patient, a number of 
MVCTs equal to the treatment sessions planned according to 
our fractionation scheme were fused on the reference one 
and structures were registered and manually corrected. The 
reference plan was recalculated on each MVCT scan to 
simulate a real treatment fraction. The cumulative dose was 
calculated by adding the contribution of each different 
fraction and then registered on the reference MVCT. This 
dose distribution was compared against the reference one in 
terms of target dose coverage and dose to OARs. 
 
Results: For the pelvis cases, results show no significant 
change in the target coverage, with an average PTV D95% 
decrease of 1% and a maximum daily variation of -6%, while 
the mean homogeneity index (HI) difference is less than 0.01. 
For the abdominal area, however, a clinically relevant loss in 
target coverage is found: PTV D95% decreases, on average, of 
7%, with a maximum daily variation of -23%. Target dose 
becomes less homogeneous, as shown by an average increase 
in the PTV HI of 0.08. For both districts, no clinically 
significant difference is found in the OAR DVHs. The 3D dose 
distribution analysis shows, for pelvic tumors, slight 
differences between planned dose and recalculated 
cumulative dose. For pancreatic carcinoma, local deviations 
up to 30% with respect to the planned dose can be found in 
the daily 3D dose distributions, particularly in healthy tissues 
behind the target volume. 
 
Conclusion: Results confirm that the use of beam directions 
crossing OARs with a high degree of inter-fractional variation, 
as in the abdominal region, should be minimized for actively 
scanned carbon ion beams. However, it is useful to stress 
that results obtained are patient-dependent and more 
statistics is needed to draw a general conclusion for a larger 
population. Research projects are ongoing focused on the 
improvement of in-room 3D imaging techniques and the 
development of dose fast calculation platforms for online 
treatment plans evaluation procedures that account for 
changing anatomy effects. 
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Purpose or Objective: In modern radiotherapy, Cone-Beam 
CT (CBCT) images are widely used for position verification. 
These CBCT images could also be used for dose recalculation, 
providing information for treatment evaluation and adaptive 
planning. However, dose calculations on CBCT are not 
straightforward and the accuracy for clinical cases is not well 
known [1-5]. The final goal was to determine for lung cancer 
patients the accuracy of dose calculations on CBCT images of 
two different vendors: Elekta and Varian. 
 
Material and Methods: Lung cancer patients with CBCT 
imaging (n=10 for Elekta, n=6 for Varian) and a repeated 
planning CT scan on the same day were selected. The original 
treatment plan and delineated structures were copied to the 
repeated CT and CBCT scans, and the dose was recalculated. 
For CBCT dose calculations, an adapted HU-to-electron 
density (HU-ED) table was used which was obtained by 
comparing CT values of corresponding points on the CBCT and 
repeated planning CT scan. For Varian, a bi-annual CBCT HU 
calibration was executed, while for Elekta the absence of 
CBCT HU-calibration was compensated by using a patient-
specific HU-ED table. Planning CT data were used to 
compensate for the limited FOV (Elekta) or scan length 
(Varian) of the CBCT. Finally, clinically relevant dose metrics 
were compared between the repeated CT and CBCT in order 
to assess the accuracy of dose calculations on CBCT for both 
vendors. 
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Results: Figure 1 displays the mean differences of the dose 
metrics between repeated CT and CBCT, for Varian and 
Elekta CBCT scans. For Varian, a good agreement between 
the dose distributions recalculated on CBCT and repeated CT 
was observed when a thorax-specific HU-ED table was used. 
For Elekta, the dose metrics showed larger deviations with 
the thorax-specific HU-ED table, however, using a patient-
specific HU-ED table resulted in similar accuracy as for Varian 
CBCT dose calculations. Differences between repeated CT 
and CBCT dose metrics were below 3% for both vendors.  
 
 
Conclusion: Differences between Elekta and Varian CBCT, 
including hardware, reconstruction software, HU calibration, 
FOV and scan length, resulted in different challenges for 
CBCT dose calculations for the different vendors. For Elekta 
CBCT scans, the procedure with a patient-specific HU-ED 
table resulted in similar accuracy as for Varian CBCT dose 
calculations with a general HU-ED correction for all thorax 
patients, but is more time-consuming. The vendor-specific 
corrective methods used in this study, resulted in dose 
calculations feasible for treatment re-evaluation for both 
Elekta and Varian CBCT scans. 
References: 1.Yang et al. PhysMedBiol 2007, 2.Richter et al. 
RadOnc 2008, 3. Hatton et al. PhysMedBiol 2009, 4.Fotina et 
al. RadiotherOnc 2012, 5. Dunlop et al. StrahlentherOnkol 
2015 
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Purpose or Objective: At our department, patients with cT1-
2aN0M0 laryngeal cancer are treated with volumetric-
modulated arc therapy (VMAT). The treatment plan quality is 
monitored by plan evaluations on weekly repeat CTs. The 
purpose of this study was to determine plan quality during 
treatment by recalculating the actually given dose based on 
repeat CT.  
 
Material and Methods: Three patients treated with 
accelerated radiotherapy (66-70 Gy in 2 Gy fractions) were 
selected because of over dosages exceeding 78 Gy at the 
transition from air to tissue. Each clinical VMAT plan (plan I) 
was optimized towards homogeneous dose distributions in the 
planning target volumes (PTV) and low as possible dose to the 
critical organs such as the swallowing organs at risk. The 
treatment plan quality was evaluated using weekly repeat 
CTs. In addition, two more treatment plans were made 
including a density override of 0.5 g.cm-3 for the PTV-in-air 
overlap region (plan II), and the PTV-in-air + 5 mm region 
(plan III). All plans were evaluated with the PTV-in-air region 
assigned a density override value of 0.0 and 1.0 g.cm-3 to 
simulate the initial planning scenario and to simulate 
extension of CTV-in-air, resp. Finally, the “actual given dose” 
of the clinical target volume (CTV) was estimated by 
accumulated repeat CT dose evaluations. 
 
Results: The repeat CTs showed an extending CTV towards 
the laryngeal air cavity over the course of treatment. Repeat 
CT evaluations indicated increasing max doses up to 80 Gy. 
Evaluation of plan I on the initial planning CT, using a density 
override of 1.0 g.cm-3, showed a potential dose hotspot with 
similar max dose values (80-87 Gy). When no density override 
was assigned the PTV (D98%) coverage of plan I was 
sufficient. In contrast, plan II and III showed slightly to 
moderate PTV under dosage (65 Gy), albeit within the PTV-
in-air region. However, the accumulated CTV dose (D100) 
demonstrated no clinically relevant under dosage in the CTV 
(methods plan II: 67.4 Gy and plan III 65.2 Gy). Furthermore, 
the plan optimization approach as used in plan II and III 
resulted in reduced and acceptable max dose values within 
the targets (76.9 Gy and 74.3 Gy, resp).  
 
Conclusion: Unacceptable high doses of up to 80 Gy were 
observed in VMAT plan evaluations based on weekly repeat 
CTs. To avoid these over dosages, high fluence profiles in 
PTV-in-air regions should be avoided during planning 
optimization. An alternative VMAT optimization and 
evaluation approach has been proposed for cT1-2aN0M0 
laryngeal cancer patients. 
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Purpose or Objective: At the Leeds Cancer Centre 
approximately 40% of lung patients receiving VMAT 
radiotherapy (RT) display a reduction in tumour volume when 
imaged using CBCT during treatment. The aim of this work 
was to develop a method to assess whether the dosimetric 
impact of observed anatomical changes is sufficiently 
significant to justify a treatment replan. 
 
Material and Methods: Twelve lung patients receiving FFF 
VMAT RT planned on the Monaco 3.3 treatment planning 
system (Elekta) were identified. All had been rescanned, 
recontoured and replanned due to noted tumour shrinkage. 
For lung replans the clinical aim is to continue treating the 
original target volumes, so a rigid registration was performed 
between the planning CT and the rescan CT using a mutual 
information algorithm. Target volumes and OAR were 
transferred from the planning CT to the rescan CT and 
assessed by a physicist and clinician team to ensure they 
were clinically appropriate. The original plan was 
recalculated on the rescan CT studyset and dose volume 
histogram (DVH) statistics calculated for targets and OARs on 
the rescan studyset. 
 
Results: For patients who displayed tumour changes without 
other significant internal changes the transferred target 
structures were deemed clinically acceptable with minor 
editing. Comparison of the transferred structures to the 
replan structures indicated that differences in remarking the 
targets were larger than image registration and transferral 
errors. Small variations in spinal cord and lung contours 
suggest that it is more accurate to re-contour these 
structures on the rescan CT, especially if they are receiving a 
dose close to tolerance. This method of adaptive planning 
was found to significantly reduce the replanning time. A 
notable limitation of the process was observed for patients 
who display other significant internal anatomical changes 
such as a change in lung volume or mediastina position, 
resulting in inaccurate transferred structures. Based on the 
DVH statistics for the transferred targets and re-contoured 
OAR, 9/12 plans required a full treatment replan. Although 
the target coverage was clinically acceptable the loss of 
tumour tissue meant that nearby OAR received doses above 
their tolerance. 
 
